Loading data for FBIOP — first visit, this takes a few seconds.
Fortress Biotech Inc. (FBIOP)
NasdaqCM: FBIOP
· Real-Time Price · USD
18.35
-0.04 (-0.22%)
At close: Aug 25, 2026, 4:56 PM
The price, the headline numbers and the latest news, in one place.
Fortress Biotech Inc. (FBIOP) Stock Price, Analysis & Data
-0.22% (1D)
No data available
| Bid | 18.1 |
| Market Cap | n/a |
| Revenue (ttm) | 68.47M |
| Net Income (ttm) | 103.37M |
| 1.21 | |
| -0.86 | |
| n/a | |
| n/a | |
| P/B (ttm) | 3.72 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 18.39 |
| Volume | 10,059 |
| Avg. Volume (20D) | 21,382 |
| Open | 18.36 |
| Previous Close | 18.39 |
| Day's Range | 18.20 - 18.40 |
| 52-Week Range | 6.27 - 21.43 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | Jun 14, 2024 |
About FBIOP
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical ...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 78
Stock Exchange NasdaqCM
Ticker Symbol FBIOP
Website https://www.fortressbiotech.com
Financial Performance
In 2025, Fortress Biotech's revenue was 63.26M, an increase of 9.69% compared to the previous year's 57.67M. Earnings were 6.82M, a decrease of -114.82%.
Financial Statements
Page 1 of 2